Home โบ Macular Edema
Macular Edema clinical trials recruiting in the U.S.
8 studies for Macular Edema are recruiting participants at sites across the United States.
Cities with the most studies
- San Antonio, TX4 studies
- Austin, TX4 studies
- Hagerstown, MD4 studies
- Raleigh, NC4 studies
- Phoenix, AZ3 studies
- Eugene, OR3 studies
- Fort Lauderdale, FL3 studies
- Nashville, TN3 studies
- Carmel, IN3 studies
- Cleveland, OH3 studies
- The Woodlands, TX3 studies
- Pasadena, CA3 studies
- Glendale, CA3 studies
- Sacramento, CA3 studies
- Denver, CO3 studies
- Columbia, SC3 studies
- Houston, TX3 studies
- Cypress, TX3 studies
- Charleston, SC3 studies
- Boston, MA3 studies
By state
- Arizona3 studies
- California4 studies
- Colorado4 studies
- Connecticut3 studies
- Florida5 studies
- Indiana3 studies
- Maryland4 studies
- Massachusetts3 studies
- New Jersey3 studies
- New York3 studies
- North Carolina6 studies
- Ohio3 studies
- Oregon3 studies
- Pennsylvania3 studies
- South Carolina5 studies
- Tennessee4 studies
- Texas5 studies
Recently updated studies
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06962839A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT07705607Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
RecruitingPhase 1
Ages 18 to 65 ยท All sexes ยท Updated Jun 5, 2026 ยท NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated May 18, 2026 ยท NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated May 18, 2026 ยท NCT06996080Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
RecruitingPhase 1/2
Ages 18 to 85 ยท All sexes ยท Updated Nov 26, 2025 ยท NCT04225611Imaging Retinal Vasculature in Infant Eyes
RecruitingObservational study
2 Months ยท All sexes ยท Updated Oct 6, 2025 ยท NCT05558059From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.